Follow The Follow-On Money: Obama’s Budget Has Modest Biogeneric Savings
Executive Summary
The fiscal 2010 federal budget outlined by the Obama administration Feb. 25 takes a conservative view of the fiscal benefit of generic biologics - estimating they will contribute $9.2 billion over 10 years to help pay for health care reform
You may also be interested in...
Biden Leaves US FDA Largely Out Of Budget Outline
FDA is only mentioned once in the document, and its temporary leadership may not be the reason why.
Follow-on Biologics Savings Lower In Administration Budget Proposal
The Obama administration has cut by about one-third its estimate of the fiscal benefit expected to accrue to the treasury from an approval pathway for follow-on biologics
Follow-on Biologics Savings Lower In Administration Budget Proposal
The Obama administration has cut by about one-third its estimate of the fiscal benefit expected to accrue to the treasury from an approval pathway for follow-on biologics